MXPA03004913A - Usos de genes de mamifero y reactivos relacionados. - Google Patents

Usos de genes de mamifero y reactivos relacionados.

Info

Publication number
MXPA03004913A
MXPA03004913A MXPA03004913A MXPA03004913A MXPA03004913A MX PA03004913 A MXPA03004913 A MX PA03004913A MX PA03004913 A MXPA03004913 A MX PA03004913A MX PA03004913 A MXPA03004913 A MX PA03004913A MX PA03004913 A MXPA03004913 A MX PA03004913A
Authority
MX
Mexico
Prior art keywords
mammalian genes
related reagents
reagents
chemokine
correlations
Prior art date
Application number
MXPA03004913A
Other languages
English (en)
Inventor
Albert Zlotnik
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MXPA03004913A publication Critical patent/MXPA03004913A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/195—Chemokines, e.g. RANTES
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2053—IL-8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MXPA03004913A 2000-12-01 2001-11-27 Usos de genes de mamifero y reactivos relacionados. MXPA03004913A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25078200P 2000-12-01 2000-12-01
PCT/US2001/044338 WO2002043758A2 (en) 2000-12-01 2001-11-27 Uses of mammalian genes and related reagents

Publications (1)

Publication Number Publication Date
MXPA03004913A true MXPA03004913A (es) 2003-09-05

Family

ID=22949122

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03004913A MXPA03004913A (es) 2000-12-01 2001-11-27 Usos de genes de mamifero y reactivos relacionados.

Country Status (7)

Country Link
US (1) US20020111290A1 (es)
EP (1) EP1399184A2 (es)
JP (1) JP2004517078A (es)
AU (1) AU2002225756A1 (es)
CA (1) CA2430401A1 (es)
MX (1) MXPA03004913A (es)
WO (1) WO2002043758A2 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101086533B1 (ko) 2002-05-24 2011-11-23 쉐링 코포레이션 중화 사람 항-ｉｇｆｒ 항체, 이를 제조하는 방법 및 이를 포함하는 조성물
ATE359297T1 (de) 2002-06-12 2007-05-15 Applied Research Systems Antagonisten für cxcr3-bindende cxc-chemokine
US20140170116A9 (en) * 2002-08-22 2014-06-19 Marc S. Penn Method of treating ischemic disorders
US20050271639A1 (en) * 2002-08-22 2005-12-08 Penn Marc S Genetically engineered cells for therapeutic applications
US7964194B2 (en) * 2002-11-15 2011-06-21 Morehouse School Of Medicine Anti-chemokine and associated receptor antibodies and uses for inhibition of inflammation
DE602004020378D1 (de) * 2003-10-01 2009-05-14 Shiseido Co Ltd Verfahren zur vorhersage der pickelbildung auf der haut unter verwendung von pickelstellen beschleunigenden genen zur anzeige sowie screening-verfahren für einen inhibitor gegen pickelbildung auf der haut
EP1694850B1 (en) 2003-11-12 2011-06-29 Schering Corporation Plasmid system for multigene expression
TW200526684A (en) 2003-11-21 2005-08-16 Schering Corp Anti-IGFR1 antibody therapeutic combinations
EP1738175A2 (en) * 2004-03-22 2007-01-03 Novartis AG Chemokine ccl18 as a biomarker
CA2501422C (en) * 2004-04-29 2014-08-12 University Of Rochester Lymphoid chemokines in the diagnosis, monitoring and treatment of autoimmune disease
EP1803464A4 (en) * 2004-09-17 2009-09-09 Cellgentech Inc TOPICAL PREPARATION FOR THE TREATMENT OF SKIN DISEASES
PT1828249E (pt) 2004-12-03 2011-02-25 Schering Corp Biomarcadores para a pré-selecção de pacientes para terapêutica anti-igf1r
US20070141627A1 (en) * 2005-10-19 2007-06-21 Behrens Timothy W Systemic Lupus Erythematosus
WO2007077257A2 (en) * 2006-01-05 2007-07-12 Galderma Research & Development Acne lesions biomarkers and modulators thereof
GB0607774D0 (en) * 2006-04-20 2006-05-31 Renovo Group Plc Medicaments
US7696309B2 (en) * 2006-10-23 2010-04-13 The Brigham And Women's Hospital, Inc. Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
DK2185719T3 (en) 2007-08-02 2014-02-17 Novimmune Sa ANTI-RANTES ANTIBODIES AND PROCEDURES FOR USE THEREOF
KR101000608B1 (ko) 2007-11-19 2010-12-10 (주)아모레퍼시픽 검버섯 발생 진단 키트 및 검버섯 발생 진단 방법
WO2009079451A2 (en) * 2007-12-14 2009-06-25 The Cleveland Clinic Foundation Compositions and methods of promoting wound healing
JP2012233693A (ja) * 2009-08-26 2012-11-29 Sapporo Medical Univ 宿主対移植片疾患の検査方法
CA2772610C (en) 2009-08-28 2018-01-23 The Cleveland Clinic Foundation Sdf-1 delivery for treating ischemic tissue
US9308277B2 (en) 2010-02-25 2016-04-12 Mesoblast International Sàrl Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
EP2566500B1 (en) 2010-05-05 2017-04-12 Rappaport Family Institute for Research in the Medical Sciences Ccl1 for use in therapy
CN103347896B (zh) 2010-09-02 2017-06-13 瓦西尼斯公司 抗cxcl13抗体和其使用方法
AU2012268078B2 (en) 2011-06-07 2017-06-01 Mesoblast International Sarl Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived Factor-1
NZ629828A (en) 2012-03-02 2017-05-26 Vaccinex Inc Methods for the treatment of b cell-mediated inflammatory diseases
CA2899344C (en) 2013-01-31 2022-11-08 Vaccinex, Inc. Methods for increasing immunoglobulin a levels
JP6618191B2 (ja) * 2014-03-27 2019-12-11 国立研究開発法人医薬基盤・健康・栄養研究所 脳マラリアの診断および治療
KR102152637B1 (ko) * 2014-07-31 2020-09-08 (주)아모레퍼시픽 케모카인을 함유하는 피부 미백용 조성물
SG10201606949QA (en) 2016-08-19 2018-03-28 Singapore Health Serv Pte Ltd Immunosuppressive composition for use in treating immunological disorders
EP3312608B1 (en) * 2016-10-24 2019-10-02 Akribes Biomedical GmbH Methods for identifying a non-healing skin wound and for monitoring the healing of a skin wound
EP4194565A4 (en) * 2020-08-10 2024-05-22 Cutis Biomedical Research Center MINIMALLY INVASIVE SKIN CONDITION DIAGNOSIS KIT WITH MICRONEEDLE PATCH

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981230A (en) * 1994-08-23 1999-11-09 Human Genome Sciences, Inc. Polynucleotide encoding chemokine β-4
GB9501683D0 (en) * 1995-01-27 1995-03-15 Glaxo Group Ltd Substances and their uses
CA2196691A1 (en) * 1995-06-07 1996-12-19 Ronald Godiska Macrophage derived chemokine and chemokine analogs
JPH09249570A (ja) * 1996-03-19 1997-09-22 Takeda Chem Ind Ltd ベンゾジアゼピン化合物含有ケモカイン受容体拮抗剤
JPH09255572A (ja) * 1996-03-26 1997-09-30 Takeda Chem Ind Ltd ケモカイン受容体拮抗剤
US6168784B1 (en) * 1997-09-03 2001-01-02 Gryphon Sciences N-terminal modifications of RANTES and methods of use
AR015425A1 (es) * 1997-09-05 2001-05-02 Smithkline Beecham Corp Compuestos de benzotiazol, composicion farmaceutica que los contiene, su uso en la manufactura de un medicamento, procedimiento para su preparacion,compuestos intermediarios y procedimiento para su preparacion
CA2303343C (en) * 1997-09-16 2011-01-04 Toray Industries, Inc. C-c chemokine production inhibitor
US6245332B1 (en) * 1999-01-15 2001-06-12 The Board Of Trustees Of The Leland Stanford Junior University Modulation of systemic memory T cell trafficking
US6248755B1 (en) * 1999-04-06 2001-06-19 Merck & Co., Inc. Pyrrolidine modulators of chemokine receptor activity

Also Published As

Publication number Publication date
WO2002043758A3 (en) 2003-12-11
EP1399184A2 (en) 2004-03-24
WO2002043758A2 (en) 2002-06-06
JP2004517078A (ja) 2004-06-10
US20020111290A1 (en) 2002-08-15
CA2430401A1 (en) 2002-06-06
AU2002225756A1 (en) 2002-06-11

Similar Documents

Publication Publication Date Title
MXPA03004913A (es) Usos de genes de mamifero y reactivos relacionados.
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
HK1046287A1 (en) Ibd-associated microbial antigens and methods of using same
AU2003295600A8 (en) Functional and hyperfunctional sirna
EP0861262A4 (en) GROUPS FOR CATCHING NUCLEIC ACIDS
ES2127514T3 (es) Ensayo de union utilizando agentes de union con grupos cola.
ATE346156T1 (de) Umkehrtransfektionsverfahren
NO20013485D0 (no) Hydrogenbearbeidning under anvendelse av gruppe VIII/gruppe VI B katalysatorer
MXPA02012743A (es) Moleculas tipo il-17 y usos de las mismas.
HK1054980A1 (zh) 利用肝臟干細胞進行毒性分型
DE60041592D1 (de) Testverfahren für verbindungen die frühzeitige tra
ATE336591T1 (de) Nachweisverfahren für kurze sequenzvarianten
AU8881201A (en) Tnf receptor-like molecules and uses thereof
WO2001066721A3 (en) Nucleic acid sensor molecules
ATE519772T1 (de) Vorrichtung und system mit trockener kontrollgen- verstummungszusammensetzung
IL139852A0 (en) Monoclonal antibodies directed against the g3bp protein, and uses
DK0809516T3 (da) Medicinsk kombination, som er anvendelig til transfektion og ekspression in vivo af exogener
WO2003034025A3 (en) Methods and reagents for improved cell-based assays
WO2003106681A3 (de) Antisense oligonukleotide gegen pim1
WO2001092877A3 (en) Method of identifying and/or isolating stem cells
GB9604305D0 (en) Diagnostic method and apparatus
WO2001044448A3 (en) Human oxidoreductase proteins
NZ540750A (en) Sets of oligonucleotide probes for diagnosis
WO2000020604A3 (en) Oxidoreductase molecules
WO2002010138A3 (en) Uses of mammalian genes and related reagents